Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So then why is this stock mired in the muck so far below .01 when (a) numerous other stem cell companies and (b) other biotechs with ZERO revenues have PPS and MC that are MASSIVELY higher? Serious question.
They’d better get on the f’ing ball then—we’ve been hearing “soon” for over a year now! I hope that it majorly messed them up when WE drove it up to .07. Shareholders have one concern: PPS. Absent any compelling explanation to the contrary from the company, I’d hope for and contribute to the same thing again gladly. Problem now is that most of the committed investors with resources are feeling BURNED.
And, as I’ve said recently, PPS does NOT need to be predicated on ACTUAL revs (how many biotechs with ZERO revs that have PPS/MC that is in the stratosphere compared to ours?).
It never should have fallen from .07–the very definition of oversold. Now we have revs, which are likely to rise to a business-sustaining level—and yet we CONTINUE to f’ing drop?! “Oh maybe management will release a PR because of all the emails we sent”: they don’t give two $h!t$ about the ENTIRE LOT of us shareholders (sorry to be the one to tell you there’s no Santa Claus).
Please prove your assertion: if it’s not documented, it didn’t happen. If by “civil” you mean obsequious, compliant, and unquestioning, then color me “uncivil”: that’s not how I live OR how I coexist at work, at school, or at home. EVERYTHING is subject to scrutiny, interrogation, and validation: IDEAS articulated clearly and compellingly—not titles or personalities—must dictate action and interaction.
I don’t expect management to read and respond here when they don’t even respond to emails ;-D
So much for the (laughable and ludicrous) idea that we’d get news today “in response to all the emails sent yesterday from the Twitter group” et.al.: if the last year hasn’t proven that they don’t give two $h!t$ about what we (or anyone else) have to say, then nothing ever will. CELZ motto: “WE got this”...
Who can blame us, SFT? I mean SERIOUSLY—it’s time to start building their way OUTTA here already, and that starts with getting to .10-.25 by year end!
All I’m asking is that they develop and execute an efficient, intelligent, and aggressive model for training. They are clearly not doing this. If contracted physician capacity to perform CaverStem and Femcelz is the problem (and it both has been and continues to be), then CHANGE the approach! There is no legitimate reason for them to be moving so glacially as we now approach ONE YEAR in the commercialization phase.
Yes—but WHY are they so muted and inactive about this?? Moreover, it should not take multiple months to train a handful of doctors on a one-hour procedure! Cluster them together in a CENTRAL location. Have each doctor meet with and treat one patient in a SEPARATE room of the SAME facility. I’m sure patients would be willing to travel to this central location in order to get treated ASAP. Business 101: SPEED TO LEAD!!!
“Premature” is a matter of opinion: if you believed in the POTENTIAL catalysts THEN—even if they were not yet in action—then the value was (AND STILL IS) there. As I said earlier this week, many are inclined to create a false dependency between ACTUAL earnings and PPS—PPS/MC does not NEED to depend on revenues IF the business model is solid and/or spectacular.
This is how, in the end, biotechs with ZERO earnings create MC’s that reveal CELZ’ MC as the joke that it is by comparison. Big takeaway: the is NO reason why this “needs” to be in the tank—and getting WORSE despite the ARRIVAL of the very revenues on which many falsely predicate the PPS!
Why would they do a RS when several of the principals only hold about 1-2M shares each—why would they fractionalized their own stake?
They clearly believe otherwise. As I said several months ago: the scientific advisors are first rate; the business “minds” should be thrown OUT ON THEIR AZZ forthwith!
They DO NOT RESPOND to emails—even those clearly framed in a supportive and deferential tone expressing gratitude and commitment, and offering suggestions and any form of assistance. That ship sailed LONG ago...
This is beginning to smell like a scared little group that fears it has over-promised through social media and now can’t back it up.
There is NO OTHER reason for them to be so silent: either the efficacy isn’t where they said it was (which might affect physician interest—maybe THIS is why “training” for a one-hour procedure is occurring at such a glacial rate?), or the true nature of what they have is not so proprietary and special after all. Only so many rational explanations for their otherwise inexplicable silence—even as virtually the entire established value and market cap are dissipating before our very eyes: and ALL of the explanations paint an extremely unflattering picture of their approach to managing and supporting shareholder relations and, ultimately, shareholder value.
Guess what: there’s NOWHERE to hide though—many people have multiple screenshots of all those claims from the first half of 2018. A few of us have been raising critical concerns for OVER A YEAR now, and yet we get these weak, pathetic, and insincere overtures in the PRs (such as they are) assuring us that they “are aware of stockholder eagerness and thank us for our continued support. The time has come for ACTION: business, legal, and otherwise—as necessary.
And THIS is what happens when you take the ostrich approach to management and don’t listen to what intelligent people are telling you patiently and repeatedly. Instead they prefer then”we got this” mentality—when they clearly DON’T got this.
Your birthday last year was glorious, SFT! I had hoped that my birthday (8/28–the date the trial closed) would be followed shortly by a late birthday present in the form of the formal presentation of that trial’s results. Instead, we’ve been told “we are working on our paper” now for several months—even as we approach 9 months since 8/28...
2025? This better be in the .50-$1 range LONG before that! FYI: just because they don’t have the infrastructure and capacity to deal with massive demand now does NOT mean that they cannot and should not want the market cap to increase quickly and dramatically. I think this is a FALSE dependency that many are making: if their patents are truly as valuable and meaningful as they assert, then there is NO reason for them to quash the PPS. End of story.
Well, someone’s buying them—otherwise the PPS wouldn’t be going up.
I exhausted this approach MONTHS ago: it’s time for answers and action.
I would expect that MANY doctors are not trained. However, I would ALSO expect that CELZ would consolidate multiple doctors from a given area into ONE training session (even if each doctor treated a single patient in a separate room). It’s a one-hour procedure, so...,
It may be time to contact the SEC and FTC to ensure that they are not somehow engaging in intentional activities to keep the PPS down. SOMEONE has been keeping this within a very narrow trading channel for months now: it’s time to find out WHO...
So why then is the PPS still tanking?
I have always believed this, but with a DRAMATIC retracement back (.07 to around .006) at a time when all the potential and catalysts were ALREADY in place—it was merely a matter of EXECUTION—how is it wrong to ask questions and have expectations? Now we have been in the execution (commercialization) phase for approaching one year—and we are STILL in the tank. All I want is for one intelligent person to EXPLAIN what is happening!
Ditto. They have f’ed us 8 different ways with their languid, glacial, indecisive, and silent approach to shareholder value management.
Fair points all—one simple request:
Explain to me clearly and compellingly why a company with this potential and momentum (a) should continue to be BADLY under .01 (having fallen from .07 about one year ago), and (b) why investors should believe that suddenly something is going to miraculously change this status quo when recent positive developments have failed to do so?
Insane potential has always been there—that’s why smart, observant people bought in to begin with. However, they have done the bare minimum to cultivate shareholder value and do not deserve the allegiance of those few longs who are actually still left
+1
Again, no concept WHATSOEVER of managing shareholder value in ANYTHING approaching a way that the shareholders can understand—and worse yet, no awareness of that fact or desire to change it.
$64K question: how long are folks willing to wait and have their money tied up, with only trust and hope to go on? We’re at 1.5 years now...
It’s obvious that they have ZERO consideration for shareholder value in terms that the SHAREHOLDER can understand. Their approach to shareholder management relations: “Trust us blindly, meet us in a secret wooded location, leave the money on the stump, and walk away.” NOT GOOD
+1. INEFFECTIVE says it all.
What was short activity volume today?
Remember a year and a half ago some talking on here about how management wanted to get us outta this cesspool and pursue uplisting ASAP? Bwahaha
Probable—but VOLUME will fix that. However, management is doing NOTHING to attract ANY interest or activity.
The more things change...
+100
Shaking my damn head—DAILY
Well, THIS is true
Blue Sphere wrote this (not only does it have the form of a typical PR, it also identifies BLSP as the source atvthe very bottom):
https://www.accesswire.com/539720/BLUE-SPHERE-PROVIDES-HOLLAND-PROJECT-UPDATE-Sterksel-Netherlands-Development-Set-to-Move-Forward--Financing-In-Place
Thanks for your substantive replies!
This continues to be a HUGE delta for CELZ—both frequency and quality of PRs. Having said that, the quality of the writing in the Q was MUCH stronger.
In your estimation, what is a reasonable OS count—1B? Another question: now that funds APPEAR to be available (in the form of grants) based on the financial closure of the Holland project deal, does this not make it less likely that they will need to continue dilution? Lastly, given the low PPS, wonder whether they might be planning/able to engage in a buyback as a way to reduce OS as an alternative to a RS?